Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NU6300 is an inhibitor of the first covalent ATP-competitive CDK2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 347.00 | |
25 mg | 8-10 weeks | $ 1,140.00 | |
50 mg | 8-10 weeks | $ 1,490.00 | |
100 mg | 8-10 weeks | $ 1,990.00 | |
1 mL * 10 mM (in DMSO) | 8-10 weeks | $ 382.00 |
Description | NU6300 is an inhibitor of the first covalent ATP-competitive CDK2. |
Targets&IC50 | CDK2:0.16 μM |
In vitro | NU6300 blocks the inhibitor binding site. The effect was time-dependent and relatively slow, with less than 50% reduction of the apparent binding capacity in 20 hr. NU6300 is a covalent CDK2 inhibitor that illustrates the potential of using vinyl sulfones to mediate irreversible inhibition. |
Molecular Weight | 413.49 |
Formula | C20H23N5O3S |
CAS No. | 2070015-09-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (77.39 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NU6300 2070015-09-5 Microbiology/Virology Antifungal NU-6300 NU 6300 inhibitor inhibit